All 1 tracked stories fall under one category: earnings. SomaLogic is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.2. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Evolent Health
All 1 tracked stories fall under one category: earnings. SomaLogic is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.2. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. We currently track 1 Finance story that mention Evolent Health, all published on February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 85 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Evolent Health. Shared-story counts are live from our verified record — not editorial picks.
Standard BioTools and Evolent Health released their Q4 and full-year 2025 financial results, marking a critical inflection point for both the life sciences tools and value-based care sectors. The reports highlight a focus on operational efficiency and the integration of large-scale acquisitions as both companies navigate a complex macroeconomic environment.
Evolent Health is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.